Overview
Marjory Charlot is an Oncologist and a Hematologist in Chapel Hill, North Carolina. Dr. Charlot is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Charlot is currently accepting new patients.
Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
The Moses H Cone Memorial Hospital Operating Corporation
Mohamed Mohamed is a Hematologist and an Oncologist in Greensboro, North Carolina. Dr. Mohamed is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and EGFR Positive Lung Cancer. Dr. Mohamed is currently accepting new patients.
Duke Cancer Center
I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday. Dr. Melson is rated as an Elite provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Charlot isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung CancerDr. Charlot isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Charlot isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Charlot isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Charlot isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- EGFR Positive Lung CancerDr. Charlot isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Charlot isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Charlot isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Charlot isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- AngiosarcomaDr. Charlot isExperienced. Learn about Angiosarcoma.
- Breast CancerDr. Charlot isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Charlot isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Charlot isExperienced. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Charlot isExperienced. Learn about Inflammatory Breast Cancer.
- Lung NodulesDr. Charlot isExperienced. Learn about Lung Nodules.

